SEARCH HEALTH CONDITIONS BY ALPHABETS
Mevalonate Kinase Deficiency
Medications for Hyperimmunoglobulin D Outcomes
Other names: HIDS; Hyperimmunoglobulin D Periodic Fever Syndrome; Mevalonate Kinase Deficiency; MKD
About Hyperimmunoglobulin D Caution: Hyperimmunoglobulin D Syndrome (HIDS) is one of the Significant Periodic Fever Syndromes which are autoinflammatory diseases. It is. Symptoms include recurring episodes of skin lesions, lymphadenopathy, stomach aches, diarrhea, fever and joint pain. These symptoms occur without disease being present. Blood tests of immunoglobulin levels show elevated levels of IgD and levels IgA can also be raised.
Drugs Used in the Treatment of Hyperimmunoglobulin D Outcomes
This list of medications are in some way associated with, or found in the treating this particular condition.
| Drug title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| canakinumab | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: canakinumab systemic Brand title: Ilaris Medication course: interleukin inhibitors For consumers: dose, interactions, For specialists: a Z Drug Truth, AHFS DI Monograph | |||||||
| Ilaris | Rx | C | N | Insert inspection | 0.0 | ||
Generic title: canakinumab systemic Medication course: interleukin inhibitors For consumers: dose, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
Legend
| Rx | prescription-only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over the Counter |
| Away Tag | This medication might not be accepted by the FDA for the treatment of the particular condition. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus within the first trimester of pregnancy (also there isn`t any evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to show a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
| C | Animal reproduction studies have shown a negative effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved with used in pregnant women obviously outweigh potential rewards. |
| N | FDA has not classified the medication. |
| Controlled Substances Act (CSA) Schedule | |
|---|---|
| N | isn`t at the mercy of the Controlled Substances Act. |
| Inch | includes a high possibility of misuse. Has no currently accepted medical use in treatment in the USA. There`s a lack of accepted safety for use under medical supervision. |
| 2 | includes a high possibility of misuse. Features a currently accepted medical use in treatment in the USA or a currently accepted medical use with severe restrictions. Abuse may cause acute emotional or physical dependence. |
| 3 | includes a possibility for abuse less than people in schedules 1 and two. Features a currently accepted medical use in treatment in the USA. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | includes a minimal potential for abuse relative to people in program 3. It has a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence relative to people in program 3. |
| 5 | includes a minimal potential for abuse relative to people in program 4. Features a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence relative to people in program 4. |
| Alcohol | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Dtc
- S
- T
- U
- V
- W
- X
- Y
- Z
Further advice
Always ask your healthcare provider to ensure the information applies to a personal circumstances.
- Measles Prophylaxis
- Mechanical Ventilation
- Mediastinal Infection
- Medical Procedures
- Medication Allergy
- Megaloblastic Anemia
- Meibomian Cyst
- Meibomian Gland Lipogranuloma
- Melanoma, Metastatic
- Melioidosis
- Meningeal Leukemia
- Meningitis, Haemophilus Influenzae
- Meningitis, Listeriosis
- Meningitis, Lymphomatous
- Meningitis, Meningococcal
- Meningitis, Pneumococcal
- Meningitis, Streptococcus Group B
- Meningococcal Meningitis Prophylaxis
- Mental Health
- Mental Retardation
- Mercury Poisoning
- MERS‐CoV
- Mesenteric Ischemia
- Mesothelioma, Malignant
- Mesothelioma, Malignant Pleural
- Metagonimus Yokogawai, Intestinal Fluke
- Meteorism
- Methanol Poisoning
- Methemoglobinemia
- Methotrexate Overdosage
- Methotrexate Rescue
- Mevalonate Kinase Deficiency
Top USA Pharma Companies
Popular Categories
Health Condition
- Measles Prophylaxis
- Mechanical Ventilation
- Mediastinal Infection
- Medical Procedures
- Medication Allergy
- Megaloblastic Anemia
- Meibomian Cyst
- Meibomian Gland Lipogranuloma
- Melanoma, Metastatic
- Melioidosis
- Meningeal Leukemia
- Meningitis, Haemophilus Influenzae
- Meningitis, Listeriosis
- Meningitis, Lymphomatous
- Meningitis, Meningococcal
- Meningitis, Pneumococcal
- Meningitis, Streptococcus Group B
- Meningococcal Meningitis Prophylaxis
- Mental Health
- Mental Retardation
- Mercury Poisoning
- MERS‐CoV
- Mesenteric Ischemia
- Mesothelioma, Malignant
- Mesothelioma, Malignant Pleural
- Metagonimus Yokogawai, Intestinal Fluke
- Meteorism
- Methanol Poisoning
- Methemoglobinemia
- Methotrexate Overdosage
- Methotrexate Rescue
- Mevalonate Kinase Deficiency
Easily find an affordable health insurance plan
